Platelet P2 receptors: from curiosity to clinical targets (Q33951830)

30 July 2017

1 reference

title

Platelet P2 receptors: from curiosity to clinical targets (English)

1 reference

30 July 2017

Cusack NJ

1

1 reference

PubMed ID

10869698

30 July 2017

Hourani SM

series ordinal

2

1 reference

30 July 2017

1 July 2000

1 reference

Journal of the autonomic nervous system

30 July 2017

1 reference

30 July 2017

81

1 reference

30 July 2017

37-43

1 reference

30 July 2017

1-3

1 reference

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Is there a basis for distinguishing two types of P2-purinoceptor?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Identification of a receptor for ADP on blood platelets by photoaffinity labelling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

ADP receptor‐induced activation of guanine‐nucleotide‐binding proteins in human platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Extracellular ATP: effects, sources and fate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Receptors for ADP on human blood platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Multiple P2 receptor subtypes on platelets: a new interpretation of their function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Evidence for the dependence of arterial haemostasis on ADP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

The control of platelet responsiveness by agents that influence cyclic AMP metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Defective platelet activation in G alpha(q)-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

The human platelet ADP receptor activates Gi2 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Receptor-mediated calcium entry in fura-2-loaded human platelets stimulated with ADP and thrombin. Dual-wavelengths studies with Mn2+.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

ADP evokes biphasic Ca2+ influx in fura-2-loaded human platelets. Evidence for Ca2+ entry regulated by the intracellular Ca2+ store

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Purinoceptor-evoked calcium signalling in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Role of P2Y1 purinoceptor in ADP-induced platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Clopidogrel: a review of its mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Identification of a P2X1 purinoceptor expressed on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Cloning and functional expression of a brain G-protein-coupled ATP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1838%2800%2900151-X

7 January 2021

10.1016/S0165-1838(00)00151-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10869698